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Untargeted metabolomics of 
colonic digests reveals kynurenine 
pathway metabolites, dityrosine 
and 3-dehydroxycarnitine as red 
versus white meat discriminating 
metabolites
Caroline Rombouts1, Lieselot Y. Hemeryck1, Thomas Van Hecke2, Stefaan De Smet2, 
Winnok H. De Vos3,4 & Lynn Vanhaecke1
Epidemiological research has demonstrated that the consumption of red meat is an important risk 
factor for the development of colorectal cancer (CRC), diabetes mellitus and cardiovascular diseases. 
However, there is no holistic insight in the (by-) products of meat digestion that may contribute 
to disease development. To address this hiatus, an untargeted mass spectrometry (MS)-based 
metabolomics approach was used to create red versus white meat associated metabolic fingerprints 
following in vitro colonic digestion using the fecal inocula of ten healthy volunteers. Twenty-two 
metabolites were unequivocally associated with simulated colonic digestion of red meat. Several 
of these metabolites could mechanistically be linked to red meat-associated pathways including 
N’-formylkynurenine, kynurenine and kynurenic acid (all involved in tryptophan metabolism), the 
oxidative stress marker dityrosine, and 3-dehydroxycarnitine. In conclusion, the used MS-based 
metabolomics platform proved to be a powerful platform for detection of specific metabolites that 
improve the understanding of the causal relationship between red meat consumption and associated 
diseases.
Epidemiological research has consistently demonstrated that a high consumption of red and processed meat is a 
significant risk factor for the development of several kinds of adenocarcinomas, particulary CRC, cardiovascular 
diseases and diabetes mellitus1,2. Several hypotheses have been reviewed to explain the possible underlying work-
ing mechanisms, especially in relation to CRC3–5. Heterocyclic amines and polycyclic aromatic hydrocarbons 
are formed during cooking of meat, however chicken also contains high concentrations of HCAs whereas its 
consumption has not been associated with CRC3. A different hypothesis states that the fat content of red meat 
can contribute to inflammation and intestinal dysbiosis, nevertheless epidemiological research failed to find an 
association between fat and CRC4. Therefore, the main currently accepted hypothesis states that heme iron, pres-
ent in red meat, can catalyse the formation of N-nitroso compounds (NOCs) and lipid peroxidation products 
(e.g. malondialdehyde and 4-hydroxy-2-nonenal). NOCs and lipid peroxidation products can induce mutations 
and specific DNA adducts (e.g. O6-carboxymethylguanine), which might eventually lead to the transformation 
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of a normal colon crypt to an abberant crypt focus3–5. However, the association between red meat and the devel-
opment of CRC is highly complex, making it very likely that other mechanisms are involved. More specifically, 
involvement of the gut microbiome in the development of CRC and other red meat-associated diseases has been 
proposed6. Gut microbiota metabolize food components and produce a plethora of metabolites, some of which 
may be harmful to the colonic mucosae. For example, nitrogenous substrates may be putrefactively fermented by 
the gut microbiota and can result in the production of NOCs. This fermentation process is linked to the devel-
opment and progression of CRC and other bowel diseases7. Moreover, diet influences the composition of the gut 
microbiota. For example, mice on a haem-rich diet had more colonic Bacteroidetes and less Firmicutes, indicating 
that a change in the composition of the gut microbiota goes hand in hand with a shift in colonic microbial fer-
mentation products8.
Metabolomics comprises the global analysis of all small-molecule metabolites (= endpoints of the 
gene-protein-metabolite cascade) present within a biological system in a particular physiological state under a 
given set of environmental conditions9,10. As a result, metabolomics offers new opportunities to discover how diet 
influences the metabolic processes of the gut microbiome and elucidate mechanistic links between diet and gut 
microbiome-associated conditions. To achieve this, nuclear magnetic resonance (NMR) and/or MS may be used 
in combination with specialized statistical software programs and online databases11. With regard to red meat 
consumption, only urinary metabolomics studies have been published so far, wherein taurine, carnitine, creati-
nine, acylcarnitines, phophatidylcholine and hexose were identified as red meat intake-associated biomarkers12–14.
Up until now, feces or digestive fluids have not been used to investigate the red meat associated metabo-
lome. The main advantage of these biological matrices lies in the presence of colonic and/or microbially formed 
metabolites allowing a more holistic investigation of the relationship between red meat consumption and risk for 
disease development, particularly CRC.
In this study, digestive fluids were obtained by simulating the human gastrointestinal digestion of chicken 
(white meat) versus beef (red meat), whereby the gut microbiota of ten healthy volunteers were used to mimic 
colonic fermentation. Metabolomic fingerprinting of meat digestion samples was performed by untargeted 
ultra high performance liquid chromatography coupled to hybrid high-resolution orbitrap mass spectrometry 
(UHPLC-HR-Q-Orbitrap-MS), an approach that was recently successfully validated for fecal and colonic diges-
tion samples15. In addition, chemometric data analysis and further structural elucidation were performed to spe-
cifically retain and identify red meat associated colonic metabolites. These metabolites may offer new insights in 
the mechanisms underlying the causal relationship between the consumption of red meat and associated diseases.
Results
Metabolomic fingerprinting of chicken and beef digestion samples. Untargeted UHPLC-Q-
Orbitrap-HRMS metabolomics analysis was performed on in vitro colonic (T48) meat digestion samples that 
were obtained following incubation of red and white meat with the fecal inocula of ten healthy volunteers. In 
Fig. 1, a schematic overview of the study is presented. SieveTM2.1 data preprocessing resulted in 3908 (+ ioniza-
tion mode) and 778 (− ionization mode) ions. The PCA-X score plots revealed good clustering for the digestion 
samples according to meat type in both the positive and negative ionization mode (Fig. 2a,b). Datasets were 
validated by CV-ANOVA (P < 0.01) and the permutation test. The characteristics of the OPLS model were excel-
lent: R2X > 0.61, R2Y > 0.98 and Q2 > 0.97. S-plots were created to retain those metabolites that were specifically 
associated with the colonic digestion of beef as opposed to chicken meat, whereby the VIP-value was set at > 1.0. 
In total, 234 and 53 red meat associated colonic digestion metabolites were retained in the positive and negative 
ionization modes, respectively (Fig. 2c,d).
In the positive and negative ionization mode respectively, 75 and 31 associated colonic metabolites were 
annotated based on accurate mass, using the online available Human Metabolome Database (HMDB)16. Next, 
structural elucidation of these annotated metabolites was performed by means of fragmentation. The online 
Metfrag tool was used to generate the fragmentation profiles of the possible candidate structures from the HMDB. 
Twenty-two metabolites were retained (both positive and negative ions) after eliminating those metabolites with 
no corresponding fragments from the candidate structures. Tables 1 and 2 present statistical significance and 
identification data of the 22 retained discriminating red meat-associated metabolites, respectively (Tables 1 and 2). 
Of these metabolites, 3-dehydroxycarnitine and dityrosine were the most important discriminating metabolites 
between red and white meat, based on VIP-, P-value and area ratios (Table 1).
For 9 of the 22 selected metabolites, commercial standards were obtained. Based on retention time and MS/
MS spectra of the corresponding standards, the identity of kynurenic acid, kynurenine, glutarylcarnitine and 
dityrosine could be confirmed. The remaining 5 metabolites (3-hydroxybutyric acid, (± ) furaneol, pantolactone, 
4-pyridoxic acid and hexanoylcarnitine) could not be confirmed because of a distinct difference in retention 
time (> 0.20 min) (Table 2). However, the observed divergence in retention time may be due to the fact that the 
5 ‘unidentified’ metabolites are in fact isomers of the purchased analytical standards. This is definitely the case 
for 3-hydroxybutyric acid, because the shift in retention time (< 0.50 min) is relatively small, and because of 
the observed similarities in the obtained MS/MS spectra. Furthermore, in literature, two 3-hydroxybutyric acid 
isomers are described, namely 2-hydroxybutyric acid and 4-hydroxybutyric acid17. For the tentatively identified 
acylcarnitine (succinylmalonylcarnitine or methylmalonylcarnitine), analytical standards could not be obtained 
(Table 2), but their identitity was deemed very likely based on the presence of the specific 85.028 Da fragment in 
its fragmentation profile. In tandem mass spectrometry-based methods for the targeted detection of acylcarni-
tines, this is the most commonly retrieved fragment18. Hexanoylcarnitine could not be confirmed based on the 
corresponding standard (Table 2), but the specific 85.028 Da fragment was also present here, indicating that this 
metabolite probably belongs to the acylcarnitine group as well. For 3-dehydroxycarnitine, the MS/MS spectrum 
complies with the obtained MS/MS data in a study by Tsjujama et al.19. Moreover, the common 60.081 Da and 
87.044 Da fragments matched the Metfrag fragmentation data (Supplementary Fig. 1, Table 2).
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The abundance of the retained and (tentatively) identified red meat associated metabolites in the duode-
nal (T0) vs. the colonic digestion samples (T48) are presented in Fig. 3. Clustering (Pearson correlation) of the 
duodenal samples and colonic digestion samples could be observed (except for P7). On metabolite level, there 
was clustering between the acylcarnitines, with the exception of 3-dehydroxycarnitine (Fig. 3). The acylcarni-
tines were more abundant prior to colonic digestion, which indicates degradation in the colon. This was not 
the case for 3-dehydroxycarnitine, which was more abundant after colonic fermentation (Fig. 3). Additionally, 
clustering was observed between L-kynurenine, kynurenic acid and N′-formylkynurenine/L-formylkynurenine. 
Remarkably, dityrosine and 3-dehydroxycarnitine were closely clustered together and were both more abundant 
in the colon (Fig. 3). 3-Dehydroxycarnitine, dityrosine, kynurenine, L-kynurenic acid and N′-formylkynurenine 
could be potentially involved in red meat-associated diseases, i.e. CRC20,21, diabetes mellitus22 or cardiovascular 
diseases23 (Table 2). For these 5 metabolites, the MS/MS data are presented in Supplementary Figs 1–5. To further 
investigate which red meat constituents were involved in the formation of these metabolites, in vitro digestions 
were performed with carnitine and myoglobin (heme). In literature, carnitine has been described as a precursor 
of 3-dehydroxycarnitine24 while kynurenine, kynurenic acid and N-formylkynurenine originate from tryptophan 
in a chemical reaction that is catalyzed by the heme-containing enzyme indoleamine-2,3-dioxygenase (IDO-1)25. 
Dityrosine is an oxidative stress marker and can therefore result from the Fenton reaction that is catalyzed by 
heme3–5,26.
Targeted metabolomics of carnitine digestion samples. To mechanistically support the formation 
of the red meat associated acylcarnitines (especially 3-dehydroxycarnitine) during gastro-intestinal digestion, 
lysine (control) and carnitine, the latter being significantly more abundant in red as opposed to white meat24, 
were subjected to an additional simulated gastro-intestinal digestion. A targeted metabolomics approach meas-
uring 3-dehydroxycarnitine, glutarylcarnitine, the tentatively identified methylmalonylcarnitine or succinylcar-
nitine and a yet unknown acylcarnitine, was implemented. 3-Dehydroxycarnitine and glutarylcarnitine could be 
detected in the amino acid digestion samples. 3-Dehydroxycarnitine was significantly (P < 0.0001) more abun-
dant in the carnitine digests in comparison to the lysine digests after colonic fermentation (T48) (Fig. 4). For 
glutarylcarnitine, no significantly different (P > 0.05) results were obtained.
Targeted metabolomics of myoglobin digestion samples. To further investigate a possible mech-
anistic link beween heme iron and kynurenic acid, L-kynurenine, N′-formylkynurenine and dityrosine a 
gastro-intestinal digestion was set-up in which myoglobin, beef meat or a combination of both were added to 
Figure 1. Schematic overview of the study. Static in vitro digestions of beef and chicken meat were performed 
in triplicate. To simulate the colonic fermentation, fecal inocula were obtained from ten healthy volunteers with 
no history of known gastro-intestinal diseases and/or use of antibiotics at least six months prior to sampling. 
Sequentially, UHPLC-HR-Q-Orbitrap-MS-based metabolomics was performed on the meat digestion samples, 
followed by data preprocessing, multivariate statistical analysis and identification of the retained beef-associated 
metabolites.
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the digestion flask. Dityrosine, kynurenic acid, N′-formylkynurenine and L-kynurenine were significantly 
more abundant in the beef digestion samples combined with myoglobin as opposed to the beef digestion sam-
ples without myoglobin (dityrosine: P < 0.0001; kynurenic acid: P = 0.0030; N′-formylkynurenine: P = 0.0005; 
L-kynurenine: P = 0.0006) (Fig. 5). Dityrosine levels were significantly (P < 0.0001) lower in the myoglobin 
digestion samples without beef as opposed to the beef containing digestion samples, whereas kynurenic acid 
(P < 0.0001) and N′-formylkynurenine (P < 0.0001) were significantly more abundant (Fig. 5).
Discussion
In this study, the fecal inocula of ten healthy volunteers were used to simulate the gastrointestinal digestion of red 
vs. white meat. Untargeted metabolomics by means of UHPLC-Q-Orbitrap technology and multivariate statisti-
cal analysis were applied to identify novel leads towards the causal relationship between red meat consumption 
and associated diseases, particularly CRC.
In total, 22 red meat associated metabolites were (tentatively) identified following the colonic digestion of 
beef meat, using the HMDB16, MS/MS fragmentation profiles and Metfrag. The identities of kynurenic acid, 
L-kynurenine, glutarylcarnitine and dityrosine were confirmed using a corresponding standard, thus reach-
ing the highest level of confidence for identification according to Sumner et al.27. For the remaining annotated 
metabolites, the third highest level of confidence for identification was achieved, because experimental frag-
mentation profiles and standards were not available for these metabolites27. Targeted metabolomics revealed the 
presence of 3-dehydroxycarnitine in carnitine digestion samples and the presence of dityrosine, kynurenic acid, 
N′-formylkynurenine and L-kynurenine in myoglobin digestion samples. As such, specific red meat constituents 
involved in the formation of these metabolites were confirmed.
The results obtained in this study provide relevant new information to elucidate the mechanisms underly-
ing red meat associated diseases, since for several of the retained and annotated red meat associated metabo-
lites (kynurenine, kynurenic acid, N′-formylkynurenine, dityrosine and 3-dehydroxycarnitine) an involvement 
in the development of CRC, diabetes mellitus and cardiovascular diseases has been conjectured (Fig. 6). Even 
more, both 3-dehydroxycarnitine and dityrosine were the most discriminating amongst the identified red 
meat-associated metabolites between the colonic digestion of red as opposed to white meat.
N′-Formylkynurenine, kynurenine and kynurenic acid are intermediates in the catabolism of trypto-
phan, an essential amino acid that can only be obtained through the diet28. Their formation is catalyzed by 
Figure 2. Plots from multivariate statistical analysis of meat digestion samples. (a,b) Score plots of the 
PCA-X model for the colonic meat digestion samples after 48 h of incubation in positive (+ ) and negative (− ) 
ionization mode. The red, green, blue symbols represent the beef, chicken digestion and internal quality control 
(IQC) samples, respectively. (c,d) S-plots (OPLS model) for the colonic meat digestion samples after 48 h of 
incubation in positive (+ ) and negative (− ) ionization mode, wherein each dot represents a metabolite. The 
metabolites situated in the left lower quadrant are specifically associated with the digestion of chicken and the 
ones in the right upper quadrant are specifically associated with the digestion of beef (= metabolites of interest). 
The metabolites marked in red were retained for further analysis.
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the heme-containing enzyme indoleamine-2,3-dioxygenase (IDO-1), commonly expressed in all organs29. 
Additionally, active IDO-enzymes have been found in ubiquitous bacteria and fungi such as Saccharomyces 
cerevisiae and Candida albicans both prevailing in the human gut30–32. IDO-1 activity has been linked to a poor 
prognosis for different types of cancer, including CRC33. Tryptophan is not significantly higher in beef as opposed 
to chicken meat34, implying that other red meat-associated mechanisms must be involved in the formation of 
the tryptophan catabolites. In this study, the addition of myoglobin to the gastro-intestinal digestive simulations 
stimulated the formation of the tryptophan catabolites N′-formylkynurenine, kynurenine and kynurenic acid. 
Therefore, it can be hypothesized that heme catalyzes the formation or increases the activity of IDO-1 by the 
gut microbiome, since this enzyme is capable of selectively and non-covalently binding to heme32. In human 
tissue, the heme site of IDO-1 is responsible for binding molecular oxygen, which is incorporated in the sub-
strate tryptophan to form N′-formylkynurenine35. Nevertheless, literature is lacking about this mechanism in 
gut microbiota and therefore further research is warranted. Upon addition of myoglobin to beef meat, a decrease 
in the formation of N′-formylkynurenine and kynurenic acid occurred as opposed to when only myoglobin 
was added. This implies that other red meat constituents most likely partially inhibit this pathway. Nevertheless, 
the abundance of these two metabolites was still significantly (P < 0.0001) higher upon addition of myoglobin. 
Kynurenine is a ligand for the aryl hydrocarbon receptor (AhR) and activation of this receptor leads to expansion 
of Tregs cells, which are responsible for creating an immunosuppressive zone around IDO-1 expressing tumors25. 
Thus, the kynurenine pathway (KP) of tryptophan metabolism is associated with cancer progression, by means of 
promoting tumor immune escape and growth20. In contrast, kynurenic acid can inhibit tumor proliferation, for 
example, by inhibiting the mitogen activated protein kinase (MAPK) pathway36. However, another study demon-
strated the association of high levels of kynurenic acid with cognitive impairment, implicating that the abundance 
of this metabolite determines its biological effect37. Additionally, KP metabolites such as 3-hydroxykynurenine 
and 3-hydroxyanthranilic acid can induce the formation of reactive oxygen species (ROS) under certain 
micro-environmental conditions, i.e. by reduction of certains metals (e.g. copper and iron) at physiological pH38. 
Given that ROS can damage DNA and induce mutations, this can lead to the transformation of a normal colon 
crypt to an abberant crypt focus, possibly resulting in the development of CRC later on refs 3–5. Moreover, KP 
metabolites have also been linked to diabetes mellitus. More specifically, kynurenic acid was increased in urine of 
animal models with diabetes type 2 and inhibited pro-insulin synthesis in rats22,39.
Dityrosine has been proposed as a biomarker of oxidative stress and has been linked to several pathologies. For 
example, dityrosine concentration levels were significantly higher in low-density lipoproteins isolated from ath-
erosclerotic plaques in comparison to healthy tissue26. Also, systemic bacterial infections, inflammatory lung dis-
ease, neurogenerative disorders and aging are associated with elevated amounts of dityrosine40. The consumption 
Metabolites (HMDB) m/z Adduct ion Δppm VIP P-value Area ratio
But-2-enoic acid 87.04448 H+ 4.61 1.31 2.03E-5 0.49
3-Hydroxybutyric acid 105.05495 H+ 2.91 1.42 3.32E-5 0.45
(± )-Furaneol 129.05450 H+ 1.08 1.09 3.02E-5 0.63
Panto-/mevalonolactone 131.07030 H+ 0.076 1.20 6.27E-14 0.66
2-Hexenyl formate 129.09102 H+ 0.074 1.52 5.03E-8 0.46
3-Dehydroxycarnitine 146.11726 H+ 2.12 2.37 1.82E-15 0.16
Pentylbenzene 149.13216 H+ 2.28 1.37 2.19E-9 0.50
Indoleacetaldehyde 160.07542 H+ 1.83 1.88 4.29E-4 0.17
2-Phenylpropionaldehyde dimethyl acetal 181.12192 H+ 2.26 1.89 2.55E-13 0.38
4-Pyridoxic acid 184.06026 H+ 1.03 1.49 4.33E-5 0.30
Kynurenic acid 190.04955 H+ 1.80 1.23 8.25E-6 0.53
L-Kynurenine 209.09186 H+ 1.11 1.48 7.99E-9 0.46
L-Kynurenine 207.07680 H− 3.34 1.62 2.33E-7 0.39
Spermic acid 1 218.18567 H+ 3.01 1.11 9.02E-6 0.45
N′-/L-formylkynurenine 237.08652 H+ 2.05 1.69 4.66E-8 0.38
N′-/L-formylkynurenine 235.07198 H− 1.82 1.70 2.36E-7 0.38
Hexanoylcarnitine 260.18500 H+ 2.53 1.40 5.55E-4 0.015
Succinyl-/methylmalonylcarnitine 262.12766 H+ 3.35 2.07 4.17E-9 0.023
Glutarylcarnitine 276.14352 H+ 2.42 1.09 6.18E-5 0.33
Saccharopine 277.13831 H+ 4.06 1.41 1.33E-4 0.51
15 (16)-epODE 295.22595 H+ 2.86 1.49 2.66E-11 0.48
9 (S)-HPODE 313.23624 H+ 3.57 1.22 4.89E-4 0.52
9,10/12,13-TriHOME 329.23303 H− 0.89 1.48 2.05E-12 0.50
Dityrosine 359.12442 H− 1.16 3.23 8.86E-8 0.021
Table 1.  The retained beef associated colonic metabolites after multivariate statistical analysis and 
identity annotation using the Human Metabolome Database (HMDB). VIP = Variable Importance 
Plot, P-value = p-value between chicken and beef digestion samples, Area ratio = Average peak intensity of 
metabolite in chicken digestion samples/average peak intensity of metabolite in beef digestion samples.
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of red meat can lead to oxidative stress through the heme-catalyzed Fenton reaction, resulting in the formation of 
ROS and lipid peroxidation products3–5. These reaction products contribute to the formation of protein oxidation 
products, whereby tyrosine residues of proteins are oxidized, cross-linked and dityrosine is formed21, explaining 
the increased formation of dityrosine following beef digestion. Additionally, the formation of this metabolite was 
higher when beef meat was included during the digestion of myoglobin, which demonstrates the importance of 
other red meat constituents, e.g. proteins. Dityrosine could be of great value as a red meat associated oxidative 
stress marker, rather than to be causatively linked to the development of CRC. Nevertheless, to the best of our 
knowledge, this is the first time that dityrosine was proposed as specific for the colonic digestion of red meat as 
opposed to white meat. Even more, these results are complementary to a study conducted by Rysman et al.41, 
wherein the protein oxidation product 4-hydroxyphenylalanine was initially higher in beef as opposed to pork 
meat and decreased during in vitro digestion of meat. The authors suggested that 4-hydroxyphenylalanine was 
possibly transformed into dityrosine41.
Although the red meat digestion resulted in the formation of several acylcarnitines, the digestion of carnitine 
resulted solely in the formation of 3-dehydroxycarnitine and glutarylcarnitine. However, the peak intensities of 
this latter metabolite approached the detection limit, therefore giving insignificant results. A logical explanation 
for the non-production of the other acylcarnitines out of solely carnitine can be found in their presence in the red 
meat itself. As such, they are initially present in the gastro-intestinal tract and then degraded by colonic bacteria. 
In general, acylcarnitines are formed during fatty acid metabolism when long-chain acyl groups are transferred 
to carnitine by coenzyme A in the cytosol. Subsequently, the complexes are transported into the mitochondrial 
matrix for further oxidation to acetyl-CoA, an important compound in the citric acid cycle42. In the utilized 
in vitro digestion model, there is no cellular absorption of carnitine, and therefore no acylcarnitines could be 
formed and excreted in the colonic fluids. The formation of 3-dehydroxycarnitine was significantly higher in the 
carnitine as opposed to the lysine digestion samples following colonic fermentation, meaning that this acylcar-
nitine is microbially formed as opposed to the other acylcarnitines. 3-Dehydroxycarnitine has been identified 
as an intermediate metabolite in the intestinal bacterial catabolism of L-carnitine, which is more abundant in 
red meat as compared to white meat, to trimethylamine24. The latter can subsequently be converted hepatically 
into trimethylamine-N-oxide (TMAO), a compound that has been causatively linked to atherosclerosis, through 
the modification of cholesterol metabolism23. It is possible that TMAO is also involved in the onset of CRC, 
since a recently conducted prospective cohort study revealed that elevated TMAO levels in plasma are associ-
ated with higher incidence of CRC in postmenopausal women43. Although a direct causal relationship between 
3-dehydroxycarnitine, the thereof derived metabolite TMAO, and the development of CRC has not yet been 
Metabolites (HMDB)
RT Matching fragments
Sample Standard Metfrag Standard
But-2-enoic acid 1.85 NS 1/15 NS
3-Hydroxybutyric acida 1.78 2.21 3/15 8/15
( ± )-Furaneol 2.83 5.71 2/15 ND
Panto-a/mevalonolactone 5.02 5.31 1/15 7/15
2-Hexenyl formate 7.28 NS 3/15 NS
3-Dehydroxycarnitinec 0.98 NS 3/15 NS
Pentylbenzene 9.81 NS 2/15 NS
Indoleacetaldehyde 4.54 NS 1/15 NS
2-Phenylpropionaldehyde dimethyl acetal 10.42 NS 1/15 NS
4-Pyridoxic acida 6.59 3.06 1/15 ND
Kynurenic acidb,c 6.36 6.44 2/15 4/9
L-Kynurenineb,c 4.25 4.07 8/15 14/15
L-Kynurenineb,c 4.19 4.06 2/15 9/15
Spermic acid 1 0.78 NS 6/15 NS
N′-/L-formylkynureninec 4.76 NS 6/15 NS
N′-/L-formylkynureninec 4.77 NS 6/15 NS
Hexanoylcarnitinea 7.87 8.44 1/15 3/15
Succinyl-/methylmalonylcarnitine 1.57 NS NA NS
Glutarylcarnitineb 2.64 2.69 NA 5/15
Saccharopine 1.18 NS 8/15 NS
15 (16)-epODE 9.89 NS 5/15 NS
9 (S)-HPODE 10.29 NS 6/15 NS
9, 10/12,13-TriHOME 9.89 NS 3/15 NS
Dityrosineb,c 2.05 2.18 4/15 3/15
Table 2.  Structural elucidation and identification of the retained beef associated colonic metabolites. 
RT = retention time; NS = no standard available; NA = not applicable; ND = not determined. Standard 
purchased, but amismatch in retention time (> 0.20 min) or bmatching retention time (< 0.20 min), cmetabolites 
potentially involved in red meat-associated diseases (e.g. CRC, diabetes mellitus and cardiovascular diseases).
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proposed, these metabolites could offer an additional mechanistic explanation for the white meat controversy. In 
this context, the sole contribution of heme in the red meat-CRC pathway is criticized because the heme content of 
pork meat is not that different from chicken, but only pork meat is linked to the development of CRC44.
Figure 3. Heat map of red meat-associated metabolites in duodenal (T0) vs. colonic (T48) beef digestion 
samples of 10 participants (P). Hierarchical clustering was performed with Pearson correlation for all 
participants and annotated metabolites.
Figure 4. Formation of acylcarnitines in carnitine digestion samples after colonic fermentation. 
Abundance of 3-dehydroxycarnitine in the carnitine and lysine (0.5 and 5 mg added per flask) digestion 
samples. Conditions that differ significantly (P < 0.05) are annotated with a different letter and error bars 
represent the standard deviation (n = 3).
www.nature.com/scientificreports/
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A distinction in metabolite profile was observed between the duodenal and colonic digestive fluids, which 
indicates the active involvement of the colonic microbiota in the formation of the majority of the annotated 
metabolites and in particular in each of the three hypotheses formulated above. Remarkably, a close clustering 
was observed between dityrosine and 3-dehydroxycarnitine, with both metabolites being highly abundant in 
the colon. It has been demonstrated that 3-dehydroxycarnitine is formed by cecal bacteria from the Bacteroides, 
Parasutterella and Prevotella genera45. Dityrosine, on the other hand results from the enzymatic degradation of 
oxiditatively modified proteins, suggesting that bacteria with a high proteolytic activity, e.g. Bacteroides, could be 
involved46,47. The metabolites from the tryptophan pathway are also clustered together and more abundant in the 
colonic digestion samples. In line with this, the involvement of the gut microbiota in the formation of KP metab-
olites was illustrated by a study by Clarke et al.48, during which less kynurenine was produced out of tryptophan in 
germ free mice as opposed to conventional mice. However, the bacterial mechanisms in tryptophan metabolism 
remain unclear, but may involve control over degradation of tryptophan48.
Figure 5. Formation of dityrosine and kynurenine pathway (KP) metabolites in myoglobin digestion 
samples after colonic fermentation. Abundance of (a) dityrosine; (b) kynurenic acid; (c) N′-formylkynurenine; 
(d) L-kynurenine in beef, beef + 50 mg myoglobin and 50 mg myoglobin digestion samples. Conditions that 
differ significantly (P < 0.05) are annotated with a different letter and error bars represent the standard deviation 
(n = 3).
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A clear clustering of meat digestion samples following colonic fermentation was visible and a notable interin-
dividual variation occured among the ten volunteers. The distinction between different meat types most probably 
relates to their different composition, but might also be influenced by an induced change in microbial composi-
tion, i.e. different meats have a different impact on the colonic microbiota and all associated colonic metabolites. 
In this work, the microbial composition of the fecal inocula of the volunteers was not assessed in order to confirm 
this hypothesis. However, a study wherein cooked meat samples were incubated with human fecal inocula in vitro 
demonstrated that 48 h of fermentation of chicken meat is associated with a higher number of Clostridium per-
fringens/histolyticum spp. and Bifidobacterium spp. as compared to 48 h of beef fermentation49. This shift is likely 
to contribute to a different metabolic pattern. The direct impact of diet on the gut microbiome was also shown in 
a recent study in which an in vitro digestion model of the proximal colon (TIM-2 system) was used, demonstrat-
ing a shift in the composition of the microbiota and the produced bacterial metabolites following the first 24 h 
after providing a high carbohydrate diet and a high protein diet47. The observed interindividual variation can be 
explained by genetics and lifestyle factors, i.e. diet, smoking, stress and physical excercise significantly influence 
the composition of the gut microbiome50–52 and metabolome53,54. Indeed, Weir et al.55 for example demonstrated 
that the abundance of certain stool microbiota e.g. Bacteroides finegoldii, two Dialister spp., and Prevotella ruminis, 
was strongly correlated with increased stool free fatty acids and glycerol, whereas Ruminococcus spp. could be 
associated with an increase in ursodeoxycholic acid55.
To conclude, this study provides novel findings concerning the relationship between the consumption of red 
meat and the development of associated diseases, particularly CRC. We were able to confirm the identity of 
3-dehydroxycarnitine, tryptophan catabolites and dityrosine with high confidence and demonstrated the involve-
ment of the red meat constituents carnitine and heme in their microbial formation. Additionally, these metab-
olites were linked to red meat-associated diseases in literature, which make them promising in further research 
towards clarifying the responsible red meat-associated mechanisms of disease. The in vivo relevance of the newly 
discovered discriminating red meat-associated metabolites in this study must be further assessed in a large scale 
follow-up study, during which dietary intake and targeted biomarker analysis of biofluids of healthy controls and 
patients with CRC or other red meat-associated diseases are performed.
Materials and Methods
Meat preparations. Two meat preparations with fresh beef diaphragm (local slaughterhouse) and chicken 
breast (local butcher) were produced. The meat samples were chopped into cubes of approximately 1–2 cm3. 
Subcutaneous pork fat was added to obtain a total fat content of 20%. The meat preparations were minced using a 
Figure 6. Schematic representation of the involvement of dityrosine, kynurenine pathway (KP) 
metabolites and 3-dehydroxycarnitine in red meat-associated disease pathways. MDA = malondialdehyde; 
4-HNE = 4-hydroxy-2-nonenal; AhR = aryl hydrocarbon receptor.
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grinder (omega T-12) equipped with a 10 mm plate, followed by grinding through a 3.5 mm plate. The meat sam-
ples were heated in a warm water bath for 30 minutes after the core temperature had reached 90 °C. Finally, the 
meat preparations were homogenized with a food processor and stored at − 20 °C prior to the in vitro digestions.
In vitro digestions. Collection and preparation of human fecal samples. For the simulation of the colonic 
digestion, fecal material was obtained from ten volunteers (7 men and 3 women, range 22–75 years). These volun-
teers had no medical history of known gastro-intestinal diseases and did not use antibiotics for at least six months 
prior to sampling. Fecal material was processed individually and the fecal inocula were prepared as described 
previously44. All human participants gave verbal informed consent and the experimental protocols were approved 
by and in accordance with the relevant guidelines and regulations of the government agency for Innovation by 
Science and Technology (IWT), Belgium that emerged with the Fund for Scientific Research, Belgium in 2016 
(FWO-registration number 1S51116N). Submission of an application to the Ethical Committee was not necessary 
due to the voluntary non-invasive sampling procedure.
Simulated gastrointestinal digestion of meat preparations. The in vitro simulation of the gastrointestinal diges-
tion consisted of an enzymatic digestion (mouth, stomach and duodenum), followed by colonic fermentation. 
Preparation of the digestion fluids and their incubations were carried out as described by Van Hecke et al.44. 
Digestion fluids were autoclaved before use, with the exception of duodenal juice and pepsine solution 
(32 mg/100 mL). The latter was sterile filtered through a polyvinylidene fluoride membrane (0.22 μ m, 33 mm ∅ , 
Millex, USA). On the day of the in vitro digestion, 4.5 g of meat was weighed, after which different digestion fluids 
were added chronologically and incubated (37 °C). Samples were taken immediately following addition of SHIME 
(Simulator of the Human Intestinal Micobial Ecosystem) medium and fecal inoculum (duodenal samples, T0) 
for comparison and after the colonic digestion (T48). Each incubation was performed in triplicate and digestion 
samples were stored at − 80 °C until analysis.
Simulated gastrointestinal digestion of carnitine and myoglobin. Stock solutions (5 mg/mL) of carnitine and 
lysine (control) were prepared in ultrapure water (UP) (Millipore, Brussels, Belgium). Both amino acids were 
obtained from Sigma-Aldrich (St-Louis, Missouri, USA) and digested in vitro by means of the selected fecal inoc-
ulum of 1 volunteer. The in vitro digestion was performed analogue as for the meat preparations, but instead of 
4.5 g meat sample, 1 mL of undiluted stock solution, 1/10th diluted stock solution, or 1 mL of UP water (= control) 
were added to separate digestions. Additionally, 900 mg of subcutaneous pork fat was included to standardize vet 
percentage.
Myoglobin, the most important heme-containing protein in mammalian muscle tissue, was obtained from 
Sigma Aldrich (St-Louis, Missouri, USA). It was added solely or to 4.5 g beef meat at the start of the digestion 
(50 mg myoglobin per digestion flask). Additionally, digestion flasks with solely 4.5 g beef meat were included as 
control.
UHPLC-Q-Orbitrap-HRMS. All digestion samples were centrifuged (21,161 g, 5 min) and the supernatant 
was filtered through a polyvinylidene fluoride membrane (0.22 μ m, 33 mm ∅ , Millex, USA). The filtrate was then 
diluted (1/5) with UP water and transferred to a LC-MS vial. The utilized UHPLC-Orbitrap-MS method was 
developed, validated and described by Vanden Bussche et al.15. Injections of an external standard mixture con-
taining ca. 300 gastrointestinal metabolites (including amino acids, monocarboxylic acids, phenols, multicarbo-
xylic acids, amines, carbohydrates, polyols, short shain fatty acids, anorganic acids, bile salts and N-compounds) 
were carried out to assess instrumental stability. Quality control (QC) samples, made from a pool of all individual 
samples (n = 120), were used for column conditioning (external QC samples) and data normalization (internal 
QC samples). External QC samples were analyzed in triplicate preceding the batch run and internal QC sam-
ples were analyzed in duplicate after each set of 10 samples, which were analyzed in a randomized order. The 
Q-Orbitrap ExactiveTM mass analyzer (Thermo Fisher Scientific, San Jose, USA) was equipped with heated elec-
trospray ionization (HESI II), which was used in polarity switching mode. The instrument was operated in full 
scan modus with a resolution of 140,000 full width at half maximum (FWHM) at 1 Hz.
Data analysis. Untargeted data analysis. In untargeted metabolomics, different steps are required for data 
acquisition and analysis, as described by Van Meulebroek et al.56. The first phase in this general workflow involves 
data preprocessing with SieveTM 2.1 (Thermo Fisher Scientific, San Jose, USA). In this study, the data for each 
ionization mode (+ or − ) were processed separately during peak list generation to achieve better model char-
acteristics in SimcaTM 13 (see below). First, appropriate parameter settings were applied as follows: beef as the 
ratio group and reference, frame time width: 0.5 min; m/z: 53.4–800 dalton, retention time: 0–16 min; m/z width: 
10 ppm; peak intensity threshold: 1,000,000 a.u. for the meat digestion experiment. In the second step, peak 
alignment, whereby corrections for inherent chromatographic variability were made, was performed after visual 
evaluation, followed by generating chromatographic peaks (= ions) according to the previous settings. In the final 
step, a number of discriminative parameters, used to retain only the most relevant ions, were set as follows: ratio 
(the average ion abundances between samples of different groups): < 0.66 or > 1.5 and P-value < 0.05. After this, 
abundances of the residual ions were exported to an excel file. Data normalization was performed by dividing the 
peak intensity of a particular metabolite in a sample by the mean peak intensity of that metabolite in the following 
two internal QC samples15.
The second phase in the general workflow involves predictive modelling of the retained ions in the statistical 
program SimcaTM 13 (Umetrics, Malmo, Sweden) to select those metabolites that are specific for the digestion of 
beef as opposed to chicken. For this, the normalized ion abundances were imported in the statistical program. 
Data were log-transformed to induce normality and scaled by the Pareto method (dividing each variable by the 
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7:42514 | DOI: 10.1038/srep42514
square rooth of the standard deviation), which reduces the relative importance of larger values and partially pre-
serves data structure57. An unsupervised principal component analysis (PCA-X) model was created to look for 
potential outliers. This PCA-X model generates score plots in which data of different biological backgrounds are 
separated into distinct groups. Samples that cluster together represent a metabolic phenotype9. In addition, an 
orthogonal partial least squares (OPLS) model was created to reveal significant differences between the chicken 
and beef digestion samples. Herein, the variation is separated into two parts, namely the predictive variation (var-
iation that is common to both X = predictor and Y = outcome) and the orthogonal variation (variation that is not 
related to Y, i.e. technical and biological factors)58. Method-validity was verified with CV-ANOVA (P < 0.01), per-
mutation testing and after inspection of three important model characteristics (R2X, R2Y and Q2Y). CV-ANOVA 
explains the predictive and orthogonal variation in X, whilst permutation testing explains the total sum of varia-
tion in Y. R2X and R2Y are both goodness-of-fit parameters and Q2Y is a goodness-of-prediction parameter. For 
these three model characteristics, a parameter value > 0.5 indicates good model quality59. An S-plot was created in 
the OPLS model to select those metabolites that are specific for the colonic digestion of beef compared to chicken 
or carnitine compared to lysine. A variable importance in projection (VIP) plot was used to evaluate the impor-
tance of a certain metabolite (meat samples: VIP-value > 1.0, amino acid samples: VIP-value > 0.8).
Targeted data analysis. Manual data processing was performed with XcaliburTM 2.1 (Thermo Fisher sci-
entific, San Jose, USA), during which the m/z and the retention time of the red meat-associated metabolites 
were applied in the processing method. Statistical analysis was performed with SAS Enterpruise Guide 7, using 
two-way ANOVA and Tukey HSD test for post hoc comparisons, whereby a P < 0.05 was considered as statisti-
cally significant.
Metabolite annotation and identification. As a first step in the annotation of the retained red meat 
associated colonic metabolites, the online Human Metabolome Database (HMDB)16 was consulted. To this 
extent, the accurate masses of the corresponding [M + H]+ or [M −  H]− were introduced in the database search, 
and the mass deviation was set at 5 ppm.
As a second step, MS/MS fragmentation profiles were obtained for the metabolites of interest to enable further 
structure elucidation. To this end, Q-ExactiveTM hybrid Quadripole-Orbitrap mass spectrometry (Thermo Fisher 
scientific, San Jose, USA) was implemented for which the chromatographic separation and ionization settings 
were the same as described earlier15. In addition, parallel reaction monitoring (PRM) with an inclusion list of 
the metabolites of interest was excecuted, during which all products from a target metabolite are simultaneously 
monitored under conditions that offer high resolution and mass accuracy60. The following MS/MS settings were 
applied: resolution of 17,500 FWHM, AGC target of 2e4, maximum injection time of 40 ms and an isolation 
window of 2.0 m/z. Normalized collision energie was set at 20 eV. The online open-source combinatorial frag-
menter Metfrag was consulted (http://msbi.ipb-halle.de/MetFrag) to give additional information about possible 
compound identity. For every possible candidate structure, in silico fragmentation was performed using several 
heuristic rules57. Finally, a heat map of the annotated metabolites was constructed with GENE-E software (http://
www.broadinstitute.org/cancer/software/GENE-E/index.html).
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